Systems for therapeutic angiogenesis in tissue engineering.
about
Stem cell bioprocessing: fundamentals and principlesScaffolds from surgically removed kidneys as a potential source of organ transplantationVascular endothelial growth factor (VEGF) and platelet (PF-4) factor 4 inputs modulate human microvascular endothelial signaling in a three-dimensional matrix migration context.Manipulating the microvasculature and its microenvironment.Biomimetic poly(ethylene glycol)-based hydrogels as scaffolds for inducing endothelial adhesion and capillary-like network formation.Mediators leading to fibrosis - how to measure and control them in tissue engineering.The feasibility of ureteral tissue engineering using autologous veins: an orthotopic animal model with long term results.Molecular and cellular effects of in vitro shockwave treatment on lymphatic endothelial cells.Endothelial cells from embryonic stem cells in a chemically defined mediumAngiogenesis with biomaterial-based drug- and cell-delivery systems.Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor.Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis.Chorioallantoic membrane for in vivo investigation of tissue-engineered construct biocompatibility.Bioactive polymer scaffold for fabrication of vascularized engineering tissue.Experimental approaches to vascularisation within tissue engineering constructs.PDLLA scaffolds with Cu- and Zn-doped bioactive glasses having multifunctional properties for bone regeneration.Adipose tissue-derived stem cells display a proangiogenic phenotype on 3D scaffolds.Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB.Matrix-Bound VEGF Mimetic Peptides: Design and Endothelial Cell Activation in Collagen Scaffolds.Metabolic shift in density-dependent stem cell differentiationImplanted neonatal human dermal fibroblasts influence the recruitment of endothelial cells in mice.Biocompatibility of Poly-epsilon-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells.Endothelial differentiation of embryonic stem cells.Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering.Fabrication of cultured oral gingiva by tissue engineering techniques without materials of animal origin.Hypoxia induces osteogenic/angiogenic responses of bone marrow-derived mesenchymal stromal cells seeded on bone-derived scaffolds via ERK1/2 and p38 pathways.Mesoporous bioactive glass scaffolds for efficient delivery of vascular endothelial growth factor.Heparin modification of a biomimetic bone matrix for controlled release of VEGF.Sintered anorganic bone graft increases autocrine expression of VEGF, MMP-2 and MMP-9 during repair of critical-size bone defects.Calcium phosphate bone cement/mesoporous bioactive glass composites for controlled growth factor delivery.Mechanisms of vasculogenesis in 3D fibrin matrices mediated by the interaction of adipose-derived stem cells and endothelial cells.Human bone marrow mesenchymal stem cells seeded on modified collagen improved dermal regeneration in vivo.Vascular therapy for radiation cystitis.Microvascular guidance: a challenge to support the development of vascularised tissue engineering construct.Comparison studies of the in vivo treatment of full-thickness excisional wounds and burns by an artificial bilayer dermal equivalent and J-1 acellular dermal matrix.Muscle Precursor Cells for the Restoration of Irreversibly Damaged Sphincter Function3D biofabrication of vascular networks for tissue regeneration: A report on recent advances
P2860
Q24653942-537784C9-7FCB-494C-B834-479130B91FA5Q28083866-205C68D1-AE16-4B6F-BF74-D6A2A8548A4BQ30559386-56904DB6-46A1-4E5E-9C6F-49464D367438Q33893860-812BAE73-59C6-4DEE-ABEC-89AFFDCDB6DEQ34148059-379402AF-4A83-4674-8452-F826955A1F2FQ34159587-DEEB3491-F928-4373-94E6-1A0AE34F00ECQ35004765-C0FA3522-D89F-4854-B72B-13A68220FD05Q35515856-F08EBC70-C40F-477D-AEC3-0505037D53F5Q35575757-B82C83C9-C8F4-4500-A28F-AC9959D86EEEQ35837499-9E1CCE6E-0721-4919-A3A2-22F5B770DC54Q36194967-3FC75703-DAD2-4E15-9A2D-DCCC6B44BA66Q37845396-F8F50C4D-F650-43F4-AD7C-CBB98E4BC62FQ37978839-83476840-BC6C-48E9-80BA-BFF40404B389Q38004962-1357E344-863A-4B76-BFA6-9E84D6088906Q38520494-0A2CC15A-6875-4698-B07A-218CB8E3284CQ39246996-5B03FDE5-3343-4E1E-AF21-AC1ACEE7292DQ39532533-B9CFCD47-3563-40E3-B290-773865A8ABA9Q39649679-8E320475-C952-46B1-8CD0-1834468A70E3Q42578299-01885EE5-7C50-4CC1-83B6-CA0BDBA4A5AEQ42660020-317A1905-E997-40F2-8B72-7D5BB50114F2Q42850477-F2DA089F-56B8-452A-85A0-8B55CAEABD2EQ43164723-169DCFF4-C697-4D3B-AFDC-8896BB7F764FQ43184815-E494E529-2D23-44F6-9F19-A407C51A2E3CQ43189555-7D8BCB2F-38DC-4C05-8C92-1520CCE1F2BEQ43877535-D9575F00-836C-4CAF-94A3-D924492CA749Q43930278-CA01762C-B773-40C4-8B05-0FE66737CE14Q44346516-D2998733-011F-4F14-9C35-8B9AF1E1BE56Q44866799-8F7F7016-B2FD-44F7-B7AF-4F9BE3E903DCQ47185859-C5F5DE1D-DBF2-48A1-B750-45C366E950BEQ48281565-92E87115-7A64-4582-8B73-0653EAB068E5Q50451844-E3B3B3E3-C87F-46CE-AAAA-FCCCB646BAA3Q51075839-1BA1E02F-1B3B-4B74-94FF-EF98BA8E0B79Q51491377-7CDA825B-7B89-4441-B1FF-AE7A2E58BB80Q51597383-B986FF41-6E71-4105-BF9A-B2DB1EC1A237Q53547267-CC164789-8CEB-4EAF-B1B8-E88B14E142B3Q57395895-99BAC38A-54D6-403C-8EA4-372E9E74257FQ57819753-12E14985-2A00-460F-B8D7-239A183A4A2C
P2860
Systems for therapeutic angiogenesis in tissue engineering.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Systems for therapeutic angiogenesis in tissue engineering.
@en
Systems for therapeutic angiogenesis in tissue engineering.
@nl
type
label
Systems for therapeutic angiogenesis in tissue engineering.
@en
Systems for therapeutic angiogenesis in tissue engineering.
@nl
prefLabel
Systems for therapeutic angiogenesis in tissue engineering.
@en
Systems for therapeutic angiogenesis in tissue engineering.
@nl
P356
P1476
Systems for therapeutic angiogenesis in tissue engineering.
@en
P2093
P2888
P356
10.1007/PL00007070
P577
2000-02-01T00:00:00Z
P6179
1030232859